Literature DB >> 24756756

Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis.

Yang Xia1, Yi Zhu, Xiaoying Zhou, Yijiang Chen.   

Abstract

The connection between microRNA expression and cancers has been identified, and microRNAs may be considered as important prognostic biomarkers. However, it is still inconsistent whether expression of let-7 can predict prognosis in patients with multiple cancers. A meta-analysis was performed by searching PubMed, EMBASE, and ISI Web of Science databases. All data were extracted from articles comparing prognosis in patients with multiple cancers having low expression of let-7 with those having high expression. Pooled hazard ratios (HRs) and corresponding 95 % confidence intervals (CIs) were calculated. Subgroup analyses were conducted for cancer type and ethnicity. A total of 1,757 cases of multiple cancers were involved for this meta-analysis. The HR of low let-7 expression in multiple cancers was 1.80 (95 % CI 1.18-2.76), and that in lung cancer was 1.99 (95 % CI 1.17-3.40). A subgroup analysis was performed on ethnicity; combined HR was 1.61 (95 % CI 0.84-3.11) for Asians and 1.94 (95 % CI 1.11-3.39) for non-Asians. Low expression of let-7 might predict poor prognosis in patients with multiple cancers, especially in lung cancer. Furthermore, let-7 might be a biomarker in non-Asian patients with favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756756     DOI: 10.1007/s13277-014-1663-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

Review 1.  Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors:  D F Hayes; C Isaacs; V Stearns
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

2.  MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma.

Authors:  Johannes Voortman; Akiteru Goto; Jean Mendiboure; Jane J Sohn; Aaron J Schetter; Motonobu Saito; Ariane Dunant; Trung C Pham; Iacopo Petrini; Alan Lee; Mohammed A Khan; Pierre Hainaut; Jean-Pierre Pignon; Elisabeth Brambilla; Helmut H Popper; Martin Filipits; Curtis C Harris; Giuseppe Giaccone
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

3.  The roles of microRNAs in tumorigenesis and angiogenesis.

Authors:  Weining Yang; Daniel Y Lee; Yaacov Ben-David
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-06-18

4.  The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

Authors:  Liu Hong; Yu Han; Hongwei Zhang; Mengbin Li; Taiqian Gong; Li Sun; Kaichun Wu; Qingchuan Zhao; Daiming Fan
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

5.  The expression of the let-7 miRNAs and Lin28 signalling pathway in human term gestational tissues.

Authors:  H W Chan; M Lappas; S W Yi Yee; K Vaswani; M D Mitchell; G E Rice
Journal:  Placenta       Date:  2013-03-29       Impact factor: 3.481

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.

Authors:  Keijiro Sugimura; Hiroshi Miyata; Koji Tanaka; Rie Hamano; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Clin Cancer Res       Date:  2012-07-30       Impact factor: 12.531

8.  The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.

Authors:  Xiao-Yan He; Jun-xia Chen; Zheng Zhang; Chun-lei Li; Qiong-le Peng; Hui-min Peng
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-22       Impact factor: 4.553

9.  Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.

Authors:  Wei Xu; Jijun Xu; Shifeng Liu; Bo Chen; Xueli Wang; Yan Li; Yun Qian; Weihong Zhao; Jianqing Wu
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

10.  Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.

Authors:  Dejuan Kong; Elisabeth Heath; Wei Chen; Michael L Cher; Isaac Powell; Lance Heilbrun; Yiwei Li; Shadan Ali; Seema Sethi; Oudai Hassan; Clara Hwang; Nilesh Gupta; Dhananjay Chitale; Wael A Sakr; Mani Menon; Fazlul H Sarkar
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

View more
  16 in total

1.  MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.

Authors:  Jingjing Cao; Chenglin Luo; Rui Peng; Qiaoyun Guo; Kaijuan Wang; Peng Wang; Hua Ye; Chunhua Song
Journal:  Tumour Biol       Date:  2016-10-10

2.  LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.

Authors:  Jun Yang; Brian D Bennett; Shujun Luo; Kaoru Inoue; Sara A Grimm; Gary P Schroth; Pierre R Bushel; H Karimi Kinyamu; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2015-07-06       Impact factor: 4.272

Review 3.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

4.  Clinical value of exhaled breath condensate let-7 in non-small cell lung cancer.

Authors:  Jin-Liang Chen; Hui-Na Han; Xue-Dong Lv; Hang Ma; Jin-Nan Wu; Jian-Rong Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

5.  Let-7, mir-98 and mir-183 as biomarkers for cancer and schizophrenia [corrected].

Authors:  Emmanouil Rizos; Nikolaos Siafakas; Eleni Katsantoni; Eleni Skourti; Vassilios Salpeas; Ioannis Rizos; James N Tsoporis; Anastasia Kastania; Anastasia Filippopoulou; Nikolaos Xiros; Demetrios Margaritis; Thomas G Parker; Charalabos Papageorgiou; Vassilios Zoumpourlis
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 6.  11q deletion in neuroblastoma: a review of biological and clinical implications.

Authors:  Vid Mlakar; Simona Jurkovic Mlakar; Gonzalo Lopez; John M Maris; Marc Ansari; Fabienne Gumy-Pause
Journal:  Mol Cancer       Date:  2017-06-29       Impact factor: 27.401

Review 7.  Therapeutic use of microRNAs in lung cancer.

Authors:  Orazio Fortunato; Mattia Boeri; Carla Verri; Massimo Moro; Gabriella Sozzi
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

Review 8.  microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance.

Authors:  Srivatsava Naidu; Michela Garofalo
Journal:  Front Med (Lausanne)       Date:  2015-11-04

9.  Silencing Lin28 promotes apoptosis in colorectal cancer cells by upregulating let‑7c targeting of antiapoptotic BCL2L1.

Authors:  Haogang Zhang; Yaguang Zong; Gongcai Qiu; Ruichun Jia; Xunzheng Xu; Fujing Wang; Dequan Wu
Journal:  Mol Med Rep       Date:  2018-01-25       Impact factor: 2.952

Review 10.  Small RNAs, Big Diseases.

Authors:  Iwona Rzeszutek; Aditi Singh
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.